Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 1
2017 1
2018 2
2020 4
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia.
Saceda-Corralo D, Rodrigues-Barata AR, Vañó-Galván S, Jaén-Olasolo P. Saceda-Corralo D, et al. Int J Trichology. 2017 Jul-Sep;9(3):143-145. doi: 10.4103/ijt.ijt_73_16. Int J Trichology. 2017. PMID: 28932074 Free PMC article. No abstract available.
Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation.
Moftah N, Moftah N, Abd-Elaziz G, Ahmed N, Hamed Y, Ghannam B, Ibrahim M. Moftah N, et al. J Eur Acad Dermatol Venereol. 2013 Jun;27(6):686-93. doi: 10.1111/j.1468-3083.2012.04535.x. Epub 2012 Apr 6. J Eur Acad Dermatol Venereol. 2013. PMID: 22486925
OBJECTIVE: Evaluation of the efficacy and safety of mesotherapy using dutasteride-containing preparation in treatment of FPHL. ...Ultrastructural evaluation was done for three patients. RESULTS: After mesotherapy with dutasteride-containing preparation …
OBJECTIVE: Evaluation of the efficacy and safety of mesotherapy using dutasteride-containing preparation in treatment of FPHL. …
Efficacy of Intralesional and Oral Dutasteride in the Treatment of Androgenetic Alopecia: A Systematic Review.
Herz-Ruelas ME, Álvarez-Villalobos NA, Millán-Alanís JM, de León-Gutiérrez H, Ocampo-Garza SS, Gómez-Flores M, Grimalt R. Herz-Ruelas ME, et al. Skin Appendage Disord. 2020 Nov;6(6):338-345. doi: 10.1159/000510697. Epub 2020 Oct 9. Skin Appendage Disord. 2020. PMID: 33313048 Free PMC article. Review.
Mesotherapy could be a feasible alternative to avoid systemic exposure and side effects [J Pan-Arab League Dermatologist. 2009 Feb;20(1):137-45]. ...Although both interventions favor over placebo, there are not enough data to reliably compare outcomes obtained between both
Mesotherapy could be a feasible alternative to avoid systemic exposure and side effects [J Pan-Arab League Dermatologist. 2009 Feb;20
Novel drug delivery approaches for the management of hair loss.
Alsalhi W, Alalola A, Randolph M, Gwillim E, Tosti A. Alsalhi W, et al. Expert Opin Drug Deliv. 2020 Mar;17(3):287-295. doi: 10.1080/17425247.2020.1723543. Epub 2020 Feb 6. Expert Opin Drug Deliv. 2020. PMID: 32003262 Review.
Angioedema-like contact dermatitis caused by mesotherapy with dutasteride.
Magdaleno-Tapial J, Valenzuela-Oñate C, García-Legaz-Martínez M, Martínez-Domenech Á, Alonso-Carpio M, Talamantes CS, Zaragoza-Ninet MG, Zaragoza-Ninet V. Magdaleno-Tapial J, et al. Contact Dermatitis. 2020 Sep;83(3):246-247. doi: 10.1111/cod.13585. Epub 2020 Jul 1. Contact Dermatitis. 2020. PMID: 32356373 No abstract available.
Safety concerns when using novel medications to treat alopecia.
Almohanna HM, Perper M, Tosti A. Almohanna HM, et al. Expert Opin Drug Saf. 2018 Nov;17(11):1115-1128. doi: 10.1080/14740338.2018.1533549. Epub 2018 Oct 25. Expert Opin Drug Saf. 2018. PMID: 30318935 Review.
This review summarizes the safety concerns when using novel therapeutic modalities such as JAK inhibitors, hair transplantation, mesotherapy, oral minoxidil, platelet-rich plasma, microneedling, and 5alpha-reductase inhibitors for treating hair loss. ...
This review summarizes the safety concerns when using novel therapeutic modalities such as JAK inhibitors, hair transplantation, mesother
Frontal edema due to mesotherapy for androgenetic alopecia: A case series.
Melo DF, Saceda-Corralo D, Tosti A, Weffort F, Carla Jorge M, de Barros CC, de Melo Carvalho R, Starace M. Melo DF, et al. Dermatol Ther. 2021 Dec 7:e15247. doi: 10.1111/dth.15247. Online ahead of print. Dermatol Ther. 2021. PMID: 34877759
Although minimally invasive, mesotherapy may be related to mild side effects like burning, erythema and headaches, as a few reports indicate. ...In all our cases of edema, lidocaine was the anesthetic used. Minoxidil and dutasteride might also play a role as causati …
Although minimally invasive, mesotherapy may be related to mild side effects like burning, erythema and headaches, as a few reports i …
5α-Reductase inhibitors in androgenetic alopecia.
Yim E, Nole KL, Tosti A. Yim E, et al. Curr Opin Endocrinol Diabetes Obes. 2014 Dec;21(6):493-8. doi: 10.1097/MED.0000000000000112. Curr Opin Endocrinol Diabetes Obes. 2014. PMID: 25268732 Review.
PURPOSE OF REVIEW: The authors will review the current literature on efficacy and safety of 5-alpha reductase inhibitors (5alphaRIs) for androgenetic alopecia (AGA). RECENT FINDINGS: The 5alphaRI finasteride and dutasteride are effective in treating AGA and promoting hair …
PURPOSE OF REVIEW: The authors will review the current literature on efficacy and safety of 5-alpha reductase inhibitors (5alphaRIs) for and …
Prescribing Habits for Androgenic Alopecia Among Dermatologists in Spain in 2017: A Cross-Sectional Study.
Pindado-Ortega C, Saceda-Corralo D, Buendía-Castaño D, Fernández-González P, Moreno-Arrones ÓM, Fonda-Pascual P, Alegre-Sánchez A, Rodrigues-Barata AR, Vañó-Galván S. Pindado-Ortega C, et al. Actas Dermosifiliogr (Engl Ed). 2018 Jul-Aug;109(6):536-542. doi: 10.1016/j.ad.2018.02.006. Epub 2018 Apr 12. Actas Dermosifiliogr (Engl Ed). 2018. PMID: 29656764 English, Spanish.
The most common treatments prescribed for MAGA were minoxidil (98%), oral finasteride (96%), nutricosmetics (44%), topical finasteride (37%), oral dutasteride (33%), platelet-rich plasma (14%), and low-level laser therapy (8%). ...A limitation of our study is that we did n …
The most common treatments prescribed for MAGA were minoxidil (98%), oral finasteride (96%), nutricosmetics (44%), topical finasteride (37%) …